1 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.57% |
2 | HALO | Halozyme Therapeutics, Inc. | 2.86% |
3 | INSM | Insmed Incorporated | 2.83% |
4 | INCY | Incyte Corporation | 2.82% |
5 | GILD | Gilead Sciences, Inc. | 2.70% |
6 | UTHR | United Therapeutics Corporation | 2.67% |
7 | REGN | Regeneron Pharmaceuticals, Inc. | 2.58% |
8 | ABBV | AbbVie Inc. | 2.54% |
9 | NBIX | Neurocrine Biosciences, Inc. | 2.45% |
10 | BMRN | BioMarin Pharmaceutical Inc. | 2.44% |
11 | BBIO | BridgeBio Pharma, Inc. | 2.42% |
12 | AMGN | Amgen Inc. | 2.40% |
13 | BIIB | Biogen Inc. | 2.36% |
14 | NTRA | Natera, Inc. | 2.31% |
15 | MRNA | Moderna, Inc. | 2.25% |
16 | EXEL | Exelixis, Inc. | 2.22% |
17 | MDGL | Madrigal Pharmaceuticals, Inc. | 2.19% |
18 | VRTX | Vertex Pharmaceuticals Incorporated | 2.03% |
19 | EXAS | Exact Sciences Corporation | 1.80% |
20 | ROIV | Roivant Sciences Ltd. | 1.68% |
21 | CRSP | CRISPR Therapeutics AG | 1.62% |
22 | VKTX | Viking Therapeutics, Inc. | 1.54% |
23 | IONS | Ionis Pharmaceuticals, Inc. | 1.51% |
24 | RNA | Avidity Biosciences, Inc. | 1.48% |
25 | CYTK | Cytokinetics, Incorporated | 1.44% |
View XBI holdings |